Memorial Hermann announces leadership changes

Houston-based Memorial Hermann Health System has announced new roles for three of its executives which will go into effect on August 1.

In a systemwide change, Brian Dean, MPH, MBA, will become the new chief financial officer for Memorial Hermann. Since 2015, he’s served as executive vice president of academic affairs and service lines for the entire system and CEO of the system’s flagship hospital at the Texas Medical Center in Houston.

Prior to joining Memorial Hermann in 2013, he held leadership roles at Jackson Health System in Miami, University Community Health in Tampa and the University of Kentucky Chandler Medical Center in Lexington.

“It has been a true honor to serve as CEO of a campus with such a revered legacy. I’ve had the opportunity to work alongside some of the finest people in medicine who share an unwavering passion to provide innovative and healing care to our patients,” Dean said in a statement.

Replacing Dean as CEO of the system’s flagship hospital will be Greg Haralson, MS, the current CEO of Memorial Hermann’s Southwest Hospital and Sugar Land Hospital. In turn, Haralson’s leadership role at those two hospitals will be filled by Malisha Patel, MHA, the current chief operations officer at the facilities.

“During their tenures with our organization, each of these three executives have demonstrated remarkable leadership capabilities, inspiring and engaging their employees to reach above and beyond to deliver the utmost in safe, high-quality care rooted in our promise to advance the health and wellness of all of Greater Houston,” said Memorial Hermann president and CEO Chuck Stokes. “Their commitment to our patients, physician partners, employees and the organization as a whole has been paramount in helping Memorial Hermann achieve several notable successes, including national recognition for our care and operational excellence.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.